The U.S. Court of Appeals for the 4th Circuit March 31 upheld a preliminary injunction issued by the U.S. District Court for the District of West Virginia blocking the state from enforcing S.B. 325, its law requiring drug companies to provide access to 340B drug discounts to purchases through…
340B Drug Pricing Program
Submit letters on 340b rebate model by April 20.
AHA President and CEO Rick Pollack testimony before the House Committee on Energy and Commerce Subcommittee on Health on Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider Landscape.
Urge your Representative to sign Hill Letter on 340B Rebate Model.
The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect by April 1.
The AHA today urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect by April 1.
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
Good Samaritan, based in Vincennes, Ind., is a county-owned, not-for-profit health system that serves a 10-county rural region across southwest Indiana and southeast Illinois.
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on its request for information on whether to implement a 340B rebate model program. Comments on the RFI were originally due March 19.
The U.S. District Court for the District of Hawaii Feb. 23 denied a preliminary injunction requested by AstraZeneca in a case challenging the state’s law protecting 340B pricing for contract pharmacy arrangements. The court held that Hawaii’s law is not preempted by the federal law, does not…